Uterine corpus and cervical cancer.

J. S. Berek, N. F. Hacker, Kenneth D Hatch, R. C. Young

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Cancers of the cervix and uterus occur in approximately 50,000 women each year in the United States. As a group, these cancers represent our sixth most common cancer overall, are second only to breast cancer, and are roughly equal to the lung cancer incidence in women. Although they comprise 11% of all cancers in females, they represent only 4% of cancer deaths in women. This results from the effective application of surgery and radiation therapy in the management of these two malignancies as well as effective techniques for early diagnosis. The overall death rate from these two malignancies has decreased more than 70% in the last 40 years. Successful outcome rests on both early diagnosis and the careful application of established treatment approaches. This monograph summarizes the management approaches to both uterine corpus and cervical cancer and discusses the role of adjuvant therapy for these major malignancies. Detailed presentations of the management of special problems, including the uterine sarcomas, are also presented. Although standard management approaches are detailed, discussion of experimental approaches, including adjuvant hormonal treatment, single agent and combination chemotherapy, and the use of radiation sensitizers is included.

Original languageEnglish (US)
Pages (from-to)61-131
Number of pages71
JournalCurrent Problems in Cancer
Volume12
Issue number2
StatePublished - Mar 1988
Externally publishedYes

Fingerprint

Uterine Cervical Neoplasms
Neoplasms
Early Diagnosis
Radiation-Sensitizing Agents
Uterine Neoplasms
Second Primary Neoplasms
Combination Drug Therapy
Cervix Uteri
Sarcoma
Lung Neoplasms
Radiotherapy
Therapeutics
Breast Neoplasms
Mortality
Incidence

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Berek, J. S., Hacker, N. F., Hatch, K. D., & Young, R. C. (1988). Uterine corpus and cervical cancer. Current Problems in Cancer, 12(2), 61-131.

Uterine corpus and cervical cancer. / Berek, J. S.; Hacker, N. F.; Hatch, Kenneth D; Young, R. C.

In: Current Problems in Cancer, Vol. 12, No. 2, 03.1988, p. 61-131.

Research output: Contribution to journalArticle

Berek, JS, Hacker, NF, Hatch, KD & Young, RC 1988, 'Uterine corpus and cervical cancer.', Current Problems in Cancer, vol. 12, no. 2, pp. 61-131.
Berek JS, Hacker NF, Hatch KD, Young RC. Uterine corpus and cervical cancer. Current Problems in Cancer. 1988 Mar;12(2):61-131.
Berek, J. S. ; Hacker, N. F. ; Hatch, Kenneth D ; Young, R. C. / Uterine corpus and cervical cancer. In: Current Problems in Cancer. 1988 ; Vol. 12, No. 2. pp. 61-131.
@article{044bbc1c9f9c41dfb85e9c8946d5a71b,
title = "Uterine corpus and cervical cancer.",
abstract = "Cancers of the cervix and uterus occur in approximately 50,000 women each year in the United States. As a group, these cancers represent our sixth most common cancer overall, are second only to breast cancer, and are roughly equal to the lung cancer incidence in women. Although they comprise 11{\%} of all cancers in females, they represent only 4{\%} of cancer deaths in women. This results from the effective application of surgery and radiation therapy in the management of these two malignancies as well as effective techniques for early diagnosis. The overall death rate from these two malignancies has decreased more than 70{\%} in the last 40 years. Successful outcome rests on both early diagnosis and the careful application of established treatment approaches. This monograph summarizes the management approaches to both uterine corpus and cervical cancer and discusses the role of adjuvant therapy for these major malignancies. Detailed presentations of the management of special problems, including the uterine sarcomas, are also presented. Although standard management approaches are detailed, discussion of experimental approaches, including adjuvant hormonal treatment, single agent and combination chemotherapy, and the use of radiation sensitizers is included.",
author = "Berek, {J. S.} and Hacker, {N. F.} and Hatch, {Kenneth D} and Young, {R. C.}",
year = "1988",
month = "3",
language = "English (US)",
volume = "12",
pages = "61--131",
journal = "Current Problems in Cancer",
issn = "0147-0272",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Uterine corpus and cervical cancer.

AU - Berek, J. S.

AU - Hacker, N. F.

AU - Hatch, Kenneth D

AU - Young, R. C.

PY - 1988/3

Y1 - 1988/3

N2 - Cancers of the cervix and uterus occur in approximately 50,000 women each year in the United States. As a group, these cancers represent our sixth most common cancer overall, are second only to breast cancer, and are roughly equal to the lung cancer incidence in women. Although they comprise 11% of all cancers in females, they represent only 4% of cancer deaths in women. This results from the effective application of surgery and radiation therapy in the management of these two malignancies as well as effective techniques for early diagnosis. The overall death rate from these two malignancies has decreased more than 70% in the last 40 years. Successful outcome rests on both early diagnosis and the careful application of established treatment approaches. This monograph summarizes the management approaches to both uterine corpus and cervical cancer and discusses the role of adjuvant therapy for these major malignancies. Detailed presentations of the management of special problems, including the uterine sarcomas, are also presented. Although standard management approaches are detailed, discussion of experimental approaches, including adjuvant hormonal treatment, single agent and combination chemotherapy, and the use of radiation sensitizers is included.

AB - Cancers of the cervix and uterus occur in approximately 50,000 women each year in the United States. As a group, these cancers represent our sixth most common cancer overall, are second only to breast cancer, and are roughly equal to the lung cancer incidence in women. Although they comprise 11% of all cancers in females, they represent only 4% of cancer deaths in women. This results from the effective application of surgery and radiation therapy in the management of these two malignancies as well as effective techniques for early diagnosis. The overall death rate from these two malignancies has decreased more than 70% in the last 40 years. Successful outcome rests on both early diagnosis and the careful application of established treatment approaches. This monograph summarizes the management approaches to both uterine corpus and cervical cancer and discusses the role of adjuvant therapy for these major malignancies. Detailed presentations of the management of special problems, including the uterine sarcomas, are also presented. Although standard management approaches are detailed, discussion of experimental approaches, including adjuvant hormonal treatment, single agent and combination chemotherapy, and the use of radiation sensitizers is included.

UR - http://www.scopus.com/inward/record.url?scp=0023974546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023974546&partnerID=8YFLogxK

M3 - Article

C2 - 3286130

AN - SCOPUS:0023974546

VL - 12

SP - 61

EP - 131

JO - Current Problems in Cancer

JF - Current Problems in Cancer

SN - 0147-0272

IS - 2

ER -